276 Chapter 11 38. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Critical care (London, England). 2010;14(1):R15. 39. de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. The Lancet Infectious diseases. 2016;16(7):819-27. 40. McHugh L, Seldon TA, Brandon RA, Kirk JT, Rapisarda A, Sutherland AJ, et al. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. PLoS medicine. 2015;12(12):e1001916. 41. Scicluna BP, Klein Klouwenberg PM, van Vught LA, Wiewel MA, Ong DS, Zwinderman AH, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. American journal of respiratory and critical care medicine. 2015;192(7):82635. 42. Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Science translational medicine. 2016;8(322):322ra11. 43. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. The Lancet Respiratory medicine. 2016;4(4):259-71. 44. Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. The Lancet Respiratory medicine. 2017. 45. Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment Response. Critical care medicine. 2018;46(3):e242-e9. 46. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive care medicine. 2017;43(3):304-77. 47. Rosenqvist M, Fagerstrand E, Lanbeck P, Melander O, Akesson P. Sepsis Alert - a triage model that reduces time to antibiotics and length of hospital stay. Infect Dis (Lond). 2017;49(7):507-13. 48. American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American journal of respiratory and critical care medicine. 2005;171(4):388-416. 49. Martinez ML, Ferrer R, Torrents E, Guillamat-Prats R, Goma G, Suarez D, et al. Impact of Source Control in Patients With Severe Sepsis and Septic Shock. Critical care medicine. 2017;45(1):11-9. 50. Roberts JA, Taccone FS, Lipman J. Understanding PK/PD. Intensive care medicine. 2016;42(11):1797-800. 51. Jamal JA, Economou CJ, Lipman J, Roberts JA. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Current opinion in critical care. 2012;18(5):460-71. 52. Darmon M, Ranzani OT, Azoulay E. Focus on immunocompromised patients. Intensive care medicine. 2017. 53. Delsuc C, Cottereau A, Frealle E, Bienvenu AL, Dessein R, Jarraud S, et al. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. Critical care (London, England). 2015;19:421.
RkJQdWJsaXNoZXIy MTk4NDMw